Alaunos Therapeutics TCRT
NASDAQ TCRT
$1.71 +0.04 (+2.40%)
At close: Nov 10, 2026 · 4:00 PM EST

Alaunos Therapeutics (TCRT) Receivables - Other (2020 - 2021)

Updated

Alaunos Therapeutics' Receivables - Other came in at $1.1 million for Q3 2021, down 85.5% from the prior quarter.

Analysis

Alaunos Therapeutics (TCRT) Receivables - Other (2020 - 2021) Analysis & Trends

At the end of FY2020, Alaunos Therapeutics' Receivables - Other was $4.7 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Alaunos Therapeutics 4.38 Mn 576,050.88 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 1.10 Mn
Jun 30, 2021 7.60 Mn
Dec 31, 2020 4.70 Mn
API Access

Alaunos Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=TCRT&period=max&api_key=YOUR_API_KEY